Lb Pharmaceuticals Inc (LBRX)

SG&A Expenses

$25.26M

TTM · Period ending: · USD

LBRX logo

LBRX SG&A Expenses

Latest reported$25.26M
LBRX TTM SG&A Expenses ($11.11M → $25.26M)
High-resolution chart · PNG

LBRX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lb Pharmaceuticals Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
25,263,000
18,214,000
13,460,000
13,487,000
12,780,000
11,114,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.